EX-16.1 2 tm2133663d1_ex16-1.htm EXHIBIT 16.1

 

Exhibit 16.1

 

November 23, 2021

 

Securities and Exchange Commission

100 F Street N.E.

Washington, D.C. 20549

 

Commissioners:

 

We have read Item 4.01 of Jaguar Health, Inc.’s Form 8-K dated November 23, 2021, and we agree with the statements set forth in Item 4.01, insofar as they relate to our firm. We have no basis to agree or disagree with other statements made by the registrant contained in Item 4.01. 

 

Very truly yours,

 

/s/ Mayer Hoffman McCann P.C.

 

San Diego, California

 

1